Determination of Ongoing Symptoms, Quality of Life Levels, and Risk Factors in Post-COVID-19 Patients
Yıl: 2022 Cilt: 44 Sayı: 2 Sayfa Aralığı: 208 - 215 Metin Dili: İngilizce DOI: 10.14744/etd.2021.99825 İndeks Tarihi: 06-07-2022
Determination of Ongoing Symptoms, Quality of Life Levels, and Risk Factors in Post-COVID-19 Patients
Öz: Objective: Studies have reported that most post-COVID-19 patients experience post-disease symptoms, but the results of
these studies have not been interpreted correctly. The present study aimed to determine the ongoing symptoms and quality
of life levels in post-COVID-19 patients.
Materials and Methods: This cross-sectional research was carried out with 151 post-COVID-19 patients in Turkey. A
sociodemographic data form and the general quality of life scale EQ-5D-5L were used.
Results: Most of the participants completed outpatient COVID-19 treatment (93.4%). Of the participants, 84.7% had at
least one post-COVID-19 symptom and 41.7% had six or more symptoms. Fatigue (70.9%), joint pain (45.7%), and muscle
pain (38.4%) were the most common post-COVID-19 symptoms. The longest-lasting post-COVID-19 symptoms were hair
loss (104.2±51.5 days), memory problem (101.9±53.3 days), and depression (96.3±48.6 days). The mean of the visual
analog scale was 83.9±16.1 and lower in individuals with six or more post-COVID-19 symptoms (p=0.001). In female
participants, post-COVID-19 symptoms increased by 2.7 times (p=0.020). The prevalence of certain COVID-19 symptoms
was significantly higher in females (loss of smell, hair loss, and heart palpitation), those aged 40 years and older (intermittent
fever), and obese individuals (heart palpitation and intermittent fever).
Conclusion: Considering that post-COVID-19 symptoms can be seen in patients with mild illness at a high rate and for a
long period of time, patient follow-up should be given importance especially for the females, elderly, and obese.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. WHO. WHO Coronavirus (COVID-19) dashboard. Available from: URL: https://covid19.who.int/. Accessed Aug 9, 2021.
- 2. Republic of Turkey Ministry of Health. COVID-19 Information page. Available from: URL: https://covid19.saglik.gov.tr/. Accessed Aug 9, 2021.
- 3. National Institute for Health and Care Excellence (NICE). COVID-19 rapid guideline: managing the long-term effects of COVID-19. Available from: URL: https://www.nice.org.uk/guidance/ng188. Accessed Aug 9, 2021.
- 4. Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020. MMWR Morb Mortal Wkly Rep 2020; 69(30): 993–8.
- 5. Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol 2021; 93(2): 1013–22.
- 6. Carfì A, Bernabei R, Landi F; Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA 2020; 324(6): 603–5.
- 7. Wang X, Xu H, Jiang H, Wang L, Lu C, Wei X, et al. Clinical features and outcomes of discharged coronavirus disease 2019 patients: a prospective cohort study. QJM 2020; 113(9): 657–65.
- 8. Townsend L, Dowds J, O’Brien K, Sheill G, Dyer AH, O’Kelly B, et al. Persistent poor health after COVID-19 ıs not associated with respiratory complications or ınitial disease severity. Ann Am Thorac Soc 2021; 18(6): 997–1003.
- 9. Garner P. Covid-19 and fatigue—a game of snakes and ladders. The BMJ opinion. Available from: URL: https://blogs.bmj.com/ bmj/2020/05/19/paul-garner-covid-19-and-fatigue-a-game-of-snakes-and-ladders/. Accessed Feb 19, 2021.
- 10. The Atlantic. COVID-19 can last for several months: the disease’s “long-haulers” have endured relentless waves of debilitating symptoms – and disbelief from doctors and friends. Available from: URL: https:// www.msn.com/en-gb/news/coronavirus/covid-19-can-last-for-several-months/ar-BB154LME. Accessed Feb 19, 2021.
- 11. Gemelli Against COVID-19 Post-Acute Care Study Group. PostCOVID-19 global health strategies: the need for an interdisciplinary approach. Aging Clin Exp Res 2020; 32(8): 1613–20.
- 12. Reenen M, Janssen B. EQ-5D-5L user guide. Basic information on how to use the EQ-5D-5L instrument, Version 2.1. 2015. Available from: URL: https://apersu.ca/wp-content/uploads/2020/10/EQ5D-5L_User-Guide.pdf.
- 13. Erbay A. Uzamış COVID: Yeni bir tanım. Bozok Tıp Derg 2020; 10(4): 111–4.
- 14. Mahase E. Covid-19: What do we know about “long covid”? BMJ 2020; 370: m2815.
- 15. CDC Centers for Disease Control and Prevention. Long-Term Effects. Available from: URL: https://www.cdc.gov/coronavirus/2019-ncov/ long-term-effects.html. Accessed Feb 19, 2021.
- 16. Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo P, Cuapio A, et al. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci Rep 2021; 11(1): 16144.
- 17. Goërtz YMJ, Van Herck M, Delbressine JM, Vaes AW, Meys R, Machado FVC, et al. Persistent symptoms 3 months after a SARSCoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res 2020; 6(4): 00542–2020.
- 18. Townsend L, Dyer AH, Jones K, Dunne J, Mooney A, Gaffney F, et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One 2020; 15(11): e0240784.
- 19. Moreno-Pérez O, Merino E, Leon-Ramirez JM, Andres M, Ramos JM, Arenas-Jiménez J, et al; COVID19-ALC research group. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J Infect 2021; 82(3): 378–83.
- 20. Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect 2020; 81(6): e4–e6.
| APA | AKOVA İ, Gedikli M (2022). Determination of Ongoing Symptoms, Quality of Life Levels, and Risk Factors in Post-COVID-19 Patients. , 208 - 215. 10.14744/etd.2021.99825 |
| Chicago | AKOVA İREM,Gedikli Mustafa Asım Determination of Ongoing Symptoms, Quality of Life Levels, and Risk Factors in Post-COVID-19 Patients. (2022): 208 - 215. 10.14744/etd.2021.99825 |
| MLA | AKOVA İREM,Gedikli Mustafa Asım Determination of Ongoing Symptoms, Quality of Life Levels, and Risk Factors in Post-COVID-19 Patients. , 2022, ss.208 - 215. 10.14744/etd.2021.99825 |
| AMA | AKOVA İ,Gedikli M Determination of Ongoing Symptoms, Quality of Life Levels, and Risk Factors in Post-COVID-19 Patients. . 2022; 208 - 215. 10.14744/etd.2021.99825 |
| Vancouver | AKOVA İ,Gedikli M Determination of Ongoing Symptoms, Quality of Life Levels, and Risk Factors in Post-COVID-19 Patients. . 2022; 208 - 215. 10.14744/etd.2021.99825 |
| IEEE | AKOVA İ,Gedikli M "Determination of Ongoing Symptoms, Quality of Life Levels, and Risk Factors in Post-COVID-19 Patients." , ss.208 - 215, 2022. 10.14744/etd.2021.99825 |
| ISNAD | AKOVA, İREM - Gedikli, Mustafa Asım. "Determination of Ongoing Symptoms, Quality of Life Levels, and Risk Factors in Post-COVID-19 Patients". (2022), 208-215. https://doi.org/10.14744/etd.2021.99825 |
| APA | AKOVA İ, Gedikli M (2022). Determination of Ongoing Symptoms, Quality of Life Levels, and Risk Factors in Post-COVID-19 Patients. Erciyes Medical Journal, 44(2), 208 - 215. 10.14744/etd.2021.99825 |
| Chicago | AKOVA İREM,Gedikli Mustafa Asım Determination of Ongoing Symptoms, Quality of Life Levels, and Risk Factors in Post-COVID-19 Patients. Erciyes Medical Journal 44, no.2 (2022): 208 - 215. 10.14744/etd.2021.99825 |
| MLA | AKOVA İREM,Gedikli Mustafa Asım Determination of Ongoing Symptoms, Quality of Life Levels, and Risk Factors in Post-COVID-19 Patients. Erciyes Medical Journal, vol.44, no.2, 2022, ss.208 - 215. 10.14744/etd.2021.99825 |
| AMA | AKOVA İ,Gedikli M Determination of Ongoing Symptoms, Quality of Life Levels, and Risk Factors in Post-COVID-19 Patients. Erciyes Medical Journal. 2022; 44(2): 208 - 215. 10.14744/etd.2021.99825 |
| Vancouver | AKOVA İ,Gedikli M Determination of Ongoing Symptoms, Quality of Life Levels, and Risk Factors in Post-COVID-19 Patients. Erciyes Medical Journal. 2022; 44(2): 208 - 215. 10.14744/etd.2021.99825 |
| IEEE | AKOVA İ,Gedikli M "Determination of Ongoing Symptoms, Quality of Life Levels, and Risk Factors in Post-COVID-19 Patients." Erciyes Medical Journal, 44, ss.208 - 215, 2022. 10.14744/etd.2021.99825 |
| ISNAD | AKOVA, İREM - Gedikli, Mustafa Asım. "Determination of Ongoing Symptoms, Quality of Life Levels, and Risk Factors in Post-COVID-19 Patients". Erciyes Medical Journal 44/2 (2022), 208-215. https://doi.org/10.14744/etd.2021.99825 |
